Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter
Abbott CEO defends inversions amid corporate exodus furor
July 18, 2014 by Arezu Sarvestani
Covidien, Medtronic, Mylan Inc., Pershing Capital Management, Valeant Pharmaceuticals, Abbott Laboratories, Allergan Inc., GE Healthcare
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Abq6SN
Cap comentari:
Publica un comentari a l'entrada